These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8562855)
1. Hormones and/or growth factors in prostate hypertrophy, pathophysiology and treatment. Mathé G Biomed Pharmacother; 1995; 49(7-8):317-8. PubMed ID: 8562855 [No Abstract] [Full Text] [Related]
2. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens]. Solè-Balcells F J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373 [TBL] [Abstract][Full Text] [Related]
3. Pressure effects on cellular systems: is there a link with benign prostatic hyperplasia? Hegarty P; Watson RW; Hegarty NJ; Coffey RN; Fitzpatrick JM Urology; 2004 Aug; 64(2):195-200. PubMed ID: 15302460 [No Abstract] [Full Text] [Related]
4. [Pathophysiology of benign prostatic hyperplasia]. Frick J Wien Med Wochenschr; 1996; 146(8):158-60. PubMed ID: 8767399 [TBL] [Abstract][Full Text] [Related]
5. [Endocrinologic factors in the development of benign prostatic hyperplasia]. Schweikert HU; Neumann F; Tunn UW Urologe A; 1989 Nov; 28(6):317-20. PubMed ID: 2481357 [TBL] [Abstract][Full Text] [Related]
6. Conference summary on prostate growth and aging, 13-15 September 2000. Brown TR; Lee C Prostate; 2001 Jun; 48(1):54-65. PubMed ID: 11391687 [No Abstract] [Full Text] [Related]
7. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)]. Magyarsóky F Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777 [No Abstract] [Full Text] [Related]
8. Dual control by androgens and peptide growth factors of prostatic growth in human benign prostatic hyperplasia. Serio M; Fiorelli G Mol Cell Endocrinol; 1991 Jun; 78(1-2):C77-81. PubMed ID: 1718792 [No Abstract] [Full Text] [Related]
10. Etiology of benign prostatic hyperplasia. Lee C; Kozlowski JM; Grayhack JT Urol Clin North Am; 1995 May; 22(2):237-46. PubMed ID: 7539172 [TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia in the nonhuman primate. Lewis RW Prog Clin Biol Res; 1984; 145():235-55. PubMed ID: 6201877 [No Abstract] [Full Text] [Related]
12. Disorders of androgen action. Wilson JD Clin Res; 1987 Jan; 35(1):1-12. PubMed ID: 2434280 [No Abstract] [Full Text] [Related]
13. [Sex steroid hormones and growth factors--growth of the prostate]. Matuo Y; Nishi N; Wada F Tanpakushitsu Kakusan Koso; 1987 Aug; 32(9):1126-32. PubMed ID: 2447609 [No Abstract] [Full Text] [Related]
14. The function and the role of aromatase inhibitors in the treatment of BPH. el Etreby MF; Habenicht UF Prog Clin Biol Res; 1994; 386():209-30. PubMed ID: 7528389 [No Abstract] [Full Text] [Related]
15. Common characteristics of human and canine benign prostatic hyperplasia. Isaacs JT Prog Clin Biol Res; 1984; 145():217-34. PubMed ID: 6201876 [No Abstract] [Full Text] [Related]
16. Role of growth factors in benign prostatic hyperplasia. Lawson RK Eur Urol; 1997; 32 Suppl 1():22-7. PubMed ID: 9218939 [TBL] [Abstract][Full Text] [Related]
17. Hormonal signaling in prostatic hyperplasia and neoplasia. Marcelli M; Cunningham GR J Clin Endocrinol Metab; 1999 Oct; 84(10):3463-8. PubMed ID: 10522981 [No Abstract] [Full Text] [Related]
18. [Why does the prostate grow? Possible role of growth factors for development of benign prostatic hyperplasia]. Tørring N; Nexø E Ugeskr Laeger; 1997 May; 159(19):2833-5. PubMed ID: 9190708 [No Abstract] [Full Text] [Related]
19. Regulation of prostatic growth and function by peptide growth factors. Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077 [TBL] [Abstract][Full Text] [Related]